Taken together, these data demonstrate the functionality of NKAB-EGFR as a bispecific killer cell engager, mediating effective tumor cell killing by NKAR-engineered effector cells, as well as primary NK cells, which endogenously express NKG2D. The gene discussed is EGFR; the disease is neoplasm.